phenylbutazone has been researched along with sulfamethoxazole in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (64.29) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (14.29) | 29.6817 |
| 2010's | 3 (21.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Agarwal, DD; Gupta, SK; Lal, J; Thavaselvam, D | 1 |
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Ludwig, G | 1 |
| Defoort, R; Oosterlinck, W; Renders, G | 1 |
| Deligiannis, F; Fessas, P; Konstantopoulos, K; Kyriakou, D; Meletis, J; Vayopoulos, G; Yataganas, X | 1 |
| Jatlow, P | 1 |
| Floersheim, GL | 2 |
| McQueen, EG | 1 |
| Fong, PH; Ratnagopal, P; Wong, KL | 1 |
| Cheng, Y; Hu, J; Li, Y; Wu, Q; Xu, T | 1 |
1 trial(s) available for phenylbutazone and sulfamethoxazole
| Article | Year |
|---|---|
The concentration of sulphamethoxazole and trimethoprim in human prostate gland.
Topics: Administration, Oral; Aged; Clinical Trials as Topic; Drug Combinations; Humans; Injections, Intramuscular; Male; Middle Aged; Phenylbutazone; Prostate; Sulfamethoxazole; Time Factors; Trimethoprim | 1975 |
13 other study(ies) available for phenylbutazone and sulfamethoxazole
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Biological activity, design, synthesis and structure activity relationship of some novel derivatives of curcumin containing sulfonamides.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Antineoplastic Agents; Bacteria; Cell Proliferation; Curcumin; Dose-Response Relationship, Drug; Drug Design; Drug Screening Assays, Antitumor; Fungi; HCT116 Cells; HeLa Cells; Hep G2 Cells; Humans; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Sulfonamides | 2013 |
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
[Epididymitis].
Topics: Adult; Diagnosis, Differential; Drug Combinations; Epididymitis; Gonorrhea; Hernia; Humans; Infant, Newborn; Infrared Rays; Male; Orchitis; Penicillins; Phenylbutazone; Prognosis; Prostatitis; Spermatic Cord Torsion; Sulfamethoxazole; Testicular Neoplasms; Tetracycline; Trimethoprim; Tuberculosis | 1977 |
Tropical pyomyositis in a Greek adult.
Topics: Adult; Diagnosis, Differential; Dicloxacillin; Drug Combinations; Greece; Humans; Male; Myositis; Phenylbutazone; Staphylococcal Infections; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1989 |
Death-cap poisoning.
Topics: Animals; Antidotes; Chloramphenicol; Cytochromes; Humans; Mushroom Poisoning; Mycotoxins; Penicillins; Phenylbutazone; Sulfamethoxazole | 1972 |
Ultraviolet spectrophotometric analysis of barbiturates: evaluation of potential interferences.
Topics: Acetaminophen; Barbiturates; Chlorothiazide; Chlorpropamide; Dicumarol; Humans; Methods; Nicotinic Acids; Oxyphenbutazone; Phenacetin; Phenindione; Phenobarbital; Phenylbutazone; Phenytoin; Salicylates; Spectrophotometry, Ultraviolet; Sulfamethoxazole; Sulfinpyrazone; Sulfisoxazole; Theobromine; Theophylline; Warfarin | 1973 |
Antidotes to experimental -amanitin poisoning.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antidotes; Chloramphenicol; Female; Injections, Intraperitoneal; Injections, Subcutaneous; Mice; Mushroom Poisoning; Mycotoxins; Penicillin G; Phenylbutazone; Sulfamethoxazole; Trimethoprim | 1972 |
New Zealand Committee on Adverse Drug Reactions: Ninth Annual Report 1974.
Topics: Abnormalities, Drug-Induced; Adolescent; Adult; Aged; Antineoplastic Agents; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Female; Halothane; Hospitalization; Hospitals, Teaching; Humans; Hypoglycemic Agents; Infant; Male; Middle Aged; New Zealand; Nitrofurantoin; Oxprenolol; Phenylbutazone; Succinylcholine; Sulfamethoxazole; Trimethoprim | 1974 |
Antagonistic effects to phalloidin, alpha-amanitin and extracts of Amanita phalloides.
Topics: Animals; Basidiomycota; Chloramphenicol; Estradiol; Lethal Dose 50; Male; Mice; Mice, Inbred Strains; Mycotoxins; Oligopeptides; Penicillin G; Peptides, Cyclic; Phenylbutazone; Plant Extracts; Prednisolone; Rifampin; Sulfadimethoxine; Sulfamethoxazole; Testosterone; Thioctic Acid; Time Factors; Trimethoprim | 1971 |
Drug induced toxic epidermal necrolysis.
Topics: Adult; Allopurinol; Burns; Critical Care; Drug Combinations; Emergencies; Female; Humans; Middle Aged; Phenylbutazone; Stevens-Johnson Syndrome; Sulfamethoxazole; Trauma Centers; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1984 |
New insights into the interactions between dendrimers and surfactants: 2. Design of new drug formulations based on dendrimer-surfactant aggregates.
Topics: Cell Survival; Chemistry, Pharmaceutical; Dendrimers; Drug Carriers; Drug Design; HeLa Cells; Humans; Methotrexate; Molecular Structure; Phenylbutazone; Solubility; Sulfamethoxazole; Surface-Active Agents | 2009 |